|
| |
|
 |
|
|
[DISPLAY PATENT] |
|
|
|
Application no. and date | 14713808.5 (espacenet) (Federated) (European Patent Register), 20140325 | Patent/reg. no. and date | DK/EP 2978416, 20161026 | Publication date | 20160203 | Priority no. and date | EP 13161089, 20130326 | EP pub. no. and date |
EP 2978416 20160203 | Effective date | | Applicant/owner | Lipid Therapeutics GmbH, Boxbergring 107
69126 Heidelberg, DE | Applicant ref. no. | P81605364DK00E | Inventor | Keilhauer, Gerhard, Landauerstrasse 13
67125 Dannstadt, DE | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 31/01 (2006.01) , A61P 1/00 (2006.01) | Title | Farmaceutisk formulering omfattende phosphatidylcholin til behandling af colitis ulcerosa | Int. application no. | EP2014055947 | Int. publication no. | WO2014154683 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
 |